US 2004/0024016 A1 · Drug for prevention and/or therapy of endometriosis

Abstract

A drug effective for prevention and therapy of endometriosis is disclosed. The drug for prevention and/or therapy of endometriosis according to the present invention comprises an antiallergic agent as an effective ingredient.

Claims6

Dependent claims

A drug for prevention and/or therapy of endometriosis comprising an antiallergic agent as an effective ingredient.

Dependencies are inferred from the claim text.

Facts

Application

10/450,954Filed 18 Jun 2003

Priority

JP 2000-38322418 Dec 2000

Published

5 Feb 2004

Term ends

Not estimatedThe source records don’t support an estimate.

Classification8 codes

A61K 31/551
Having seven-membered rings, e.g. azelastine, pentylenetetrazole: having two nitrogen atoms, e.g. dilazep
A61K 31/41
Having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins: having five-membered rings with two or more ring hetero atoms, at least…
A61K 31/4535
Containing further heterocyclic ring systems: containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
A61K 31/55
Having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins: having seven-membered rings, e.g. azelastine, pentylenetetrazole

Abstract

Claims6

Dependent claims

A drug for prevention and/or therapy of endometriosis comprising an antiallergic agent as an effective ingredient.

Dependencies are inferred from the claim text.

Drug for prevention and/or therapy of endometriosis

Life of this patent

Abstract

Claims6

Drug for prevention and/or therapy of endometriosis

Life of this patent

Abstract

Claims6